| 000 | 01508 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515192611.0 | ||
| 264 | 0 | _c20100120 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1080-6059 | ||
| 024 | 7 |
_a10.3201/eid1510.090110 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSwart, Reinout M | |
| 245 | 0 | 0 |
_aNontuberculous mycobacteria infection and tumor necrosis factor-alpha antagonists. _h[electronic resource] |
| 260 |
_bEmerging infectious diseases _cOct 2009 |
||
| 300 |
_a1700-1 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 |
_aMycobacterium Infections _xmicrobiology |
| 650 | 0 | 4 |
_aMycobacterium haemophilum _xisolation & purification |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _avan Ingen, Jakko | |
| 700 | 1 | _avan Soolingen, Dick | |
| 700 | 1 | _aSlingerland, Rob | |
| 700 | 1 | _aHendriks, Willem D H | |
| 700 | 1 | _aden Hollander, Jan G | |
| 773 | 0 |
_tEmerging infectious diseases _gvol. 15 _gno. 10 _gp. 1700-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3201/eid1510.090110 _zAvailable from publisher's website |
| 999 |
_c19250792 _d19250792 |
||